Science

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

Federica Pecci/X

Apr 26, 2025, 16:35

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

Federica Pecci, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a paper she co-authored with colleagues published in Clinical Cancer Research,:

“Just published in Clinical Cancer Research, our work studying factors associated with prolonged disease control and survival after discontinuation of immune checkpoint inhibitors for irAEs in patients with advanced NSCLC.”

“Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer”

Authors: Federica Pecci, Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao Alessi, Mizuki Nishino, Bruce Johnson, Matthew Hellmann, Adam Schoenfeld, Mark Awad et al.

More posts featuring Federica Pecci.

Adam Schoenfeld Biagio Ricciuti Bruce Johnson cancer Clinical Cancer Research Federica Pecci João Alessi Mark Awad Matthew Hellmann Mizuki Nishino non small cell lung cancer NSCLC OncoDaily Oncology Rohit Thummalapalli Stephanie Alden

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen